Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

A RUNX-CBFbeta-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes.
Murakami K, Sasaki H, Nishiyama A, Kurotaki D, Kawase W, Ban T, Nakabayashi J, Kanzaki S, Sekita Y, Nakajima H, Ozato K, Kimura T, Tamura T
Nat Immunol. 2021 Mar;22(3):301-311. doi: 10.1038/s41590-021-00871-y. Epub 2021 Feb 18.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
83306CSII-U6-gRNA-CBh-3xFLAG-PA-dCas9-P2A-PuroLentivirus vector to express guideRNA and dCas9 with puro resistant gene

Antibodies from Article